MRC1 and neoplasm: Additionally, an examination of M2‐TAMs in tumor tissues co‐injected subcutaneously with CT26 cells and NIH3T3(LV‐VEC/LV‐VTN) cells indicated elevated F4/80 and CD206 expression in the VTN overexpression group (Figure S6A, Supporting Information).